Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 27083050)

  • 1. Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.
    Tung MC; Lin PL; Cheng YW; Wu DW; Yeh SD; Chen CY; Lee H
    Oncotarget; 2016 May; 7(22):32362-74. PubMed ID: 27083050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
    Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
    Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancer.
    Wu HH; Wu JY; Cheng YW; Chen CY; Lee MC; Goan YG; Lee H
    Clin Cancer Res; 2010 Nov; 16(21):5200-10. PubMed ID: 20959404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis.
    Cheng YW; Wu TC; Chen CY; Chou MC; Ko JL; Lee H
    Clin Cancer Res; 2008 Nov; 14(22):7173-9. PubMed ID: 19010833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.
    Chen SP; Hsu NY; Wu JY; Chen CY; Chou MC; Lee H; Cheng YW
    Ann Thorac Surg; 2013 Apr; 95(4):1196-203. PubMed ID: 23522190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
    Bourguignon LYW; Earle C; Shiina M
    Matrix Biol; 2019 May; 78-79():180-200. PubMed ID: 30077625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis.
    Chen PM; Cheng YW; Wang YC; Wu TC; Chen CY; Lee H
    Neoplasia; 2014 Nov; 16(11):961-71. PubMed ID: 25425970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway.
    Au Yeung CL; Tsang TY; Yau PL; Kwok TT
    Oncogene; 2011 May; 30(21):2401-10. PubMed ID: 21242962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation.
    Cheng YW; Wu MF; Wang J; Yeh KT; Goan YG; Chiou HL; Chen CY; Lee H
    Cancer Res; 2007 Nov; 67(22):10686-93. PubMed ID: 18006810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-30c-2* negative regulated MTA-1 expression involved in metastasis and drug resistance of HPV-infected non-small cell lung cancer.
    Wu YL; Hsu NY; Cheau-Feng Lin F; Lee H; Cheng YW
    Surgery; 2016 Dec; 160(6):1591-1598. PubMed ID: 27506865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
    Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
    Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced p21(WAF1/CIP1) via alteration of p53-DDX3 pathway is associated with poor relapse-free survival in early-stage human papillomavirus-associated lung cancer.
    Wu DW; Liu WS; Wang J; Chen CY; Cheng YW; Lee H
    Clin Cancer Res; 2011 Apr; 17(7):1895-905. PubMed ID: 21325288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
    Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
    Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3.
    Yeung CL; Tsang TY; Yau PL; Kwok TT
    Oncotarget; 2017 Feb; 8(7):12158-12173. PubMed ID: 28077801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer.
    Chen TH; Huang CC; Yeh KT; Chang SH; Chang SW; Sung WW; Cheng YW; Lee H
    World J Gastroenterol; 2012 Aug; 18(30):4051-8. PubMed ID: 22912557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of miR-22, a tumor suppressor in cervical cancer, by human papillomavirus 16 E6 via a p53/miR-22/HDAC6 pathway.
    Wongjampa W; Ekalaksananan T; Chopjitt P; Chuerduangphui J; Kleebkaow P; Patarapadungkit N; Pientong C
    PLoS One; 2018; 13(10):e0206644. PubMed ID: 30379969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
    Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells.
    Javadi H; Lotfi AS; Hosseinkhani S; Mehrani H; Amani J; Soheili ZS; Hojati Z; Kamali M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):727-736. PubMed ID: 29873516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.